1997
DOI: 10.1074/jbc.272.27.17145
|View full text |Cite
|
Sign up to set email alerts
|

p11, a Unique Member of the S100 Family of Calcium-binding Proteins, Interacts with and Inhibits the Activity of the 85-kDa Cytosolic Phospholipase A2

Abstract: Using a two hybrid system screen of a human cDNA library, we have found that p11, a unique member of the S100 family of calcium-binding proteins, interacts with the carboxyl region of the 85-kDa cytosolic phospholipase A 2 (cPLA 2 ). p11 synthesized in a cell-free system interacts with cPLA 2 in vitro. The p11-cPLA 2 complex is detectable from a human bronchial epithelial cell line (BEAS 2B). Furthermore, p11 inhibits cPLA 2 activity in vitro. Selective inhibition of p11 expression in the BEAS 2B cells by anti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
78
0
1

Year Published

1999
1999
2015
2015

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 108 publications
(81 citation statements)
references
References 60 publications
2
78
0
1
Order By: Relevance
“…The protein p11, a member of S100 family proteins, forms a heterotetrameric annexin II 2 p11 2 complex that is concentrated in caveolae [43]. This protein interacts with a large C-terminal domain of cPLA 2 , inhibiting its enzymatic activity [44]. Also, phosphatidylinositol 4,5-bisphosphate, which is concentrated in caveolae [45], interacts with a putative pleckstrin homology domain of cPLA 2 , resulting in increased enzymatic activity [17].…”
Section: Discussionmentioning
confidence: 99%
“…The protein p11, a member of S100 family proteins, forms a heterotetrameric annexin II 2 p11 2 complex that is concentrated in caveolae [43]. This protein interacts with a large C-terminal domain of cPLA 2 , inhibiting its enzymatic activity [44]. Also, phosphatidylinositol 4,5-bisphosphate, which is concentrated in caveolae [45], interacts with a putative pleckstrin homology domain of cPLA 2 , resulting in increased enzymatic activity [17].…”
Section: Discussionmentioning
confidence: 99%
“…The second major function of Anx2 is acting as a phopholipase A 2 inhibitor in combination with p11 (Haigler et al, 1987;Wu et al, 1997) involved in the inhibition of platelet aggregation, which is in accord with the recent finding that Anx2 itself is a cell-surface receptor for plasminogen and its activator t-PA (tissuetype plasminogen activator) (Hajjar and Menell, 1997). Furthermore, abnormally high levels of Anx2 on acute promyelocytic leukemia cells were found to increase the production of plasmin, a fibrinolytic protein, suggesting that overexpression of Anx2 may be responsible for the hemorrhagic complications of acute promyelocytic leukemia (Menell et al, 1999).…”
Section: Discussionmentioning
confidence: 99%
“…Activation of cPLA 2 ␣ in vascular smooth muscle cells by calcium/calmodulin-dependent kinase II that phosphorylates S515 has been described ( 101 ). Phosphorylation of cPLA 2 ␣ on S727 by MAPK-interacting kinase does not enhance catalytic activity per se, but blocks its binding to an inhibitory complex in the cytosol composed of p11(S100A10)/annexin A2 ( 74,(102)(103)(104)(105) ( Fig. 1 ).…”
Section: Downloaded Frommentioning
confidence: 99%